On the occasion of World Sickle Cell Day on 19 June, it is worth remembering that this genetic disease remains a major concern in sub-Saharan Africa, with a prevalence of up to 40% in heterozygous forms and 2% in homozygous forms. What is the current state of research and treatment for this disease, and what is its economic impact in Africa?
Blood transfusion is an essential part of today’s therapeutic arsenal, whether in gynaecology, surgery, traumatology, or for the treatment of certain diseases such as sickle cell anaemia or Ebola haemorrhagic fever. Unfortunately, blood donation in Africa is still too often hampered by beliefs that limit its effectiveness.
At the sixth summit between the European Union and the African Union in Brussels, the focus was on research and innovation as key drivers of development and cooperation in Africa. These areas are seen as catalysts for progress, and are vital for tackling global challenges such as climate change, population growth and economic recovery.